info@strategicmarketresearch.com
26, Broadway, Suite 934, New York , 10004
us US: +18317045538    uk UK: +441256636046    in IN: +918260836500
Home » Healthcare » Ligation Devices Market Size | Growth Analysis 2030

Ligation Devices Market: By Product (Handheld instruments, Accessories), By Procedure (MIS, Open Surgery), By Application(Gastrointestinal & Abdominal Surgeries, Gynecological Surgeries, Cardiovascular Surgeries, Urological Surgeries, Other Applications) By Geography, Size, Industry Analysis, Forecast, 2021-2030

Published On: Mar-2022   |   Base Year: 2021   |   No Of Pages: 135   |   Historical Data: 2017 - 2020   |   Formats: PDF   |   Report ID: 09817266

Report DescriptionTable of Contents

Industry Statistics and Insights

The global ligation devices market will witness a robust CAGR of 6.47%, valued at $992.94 million in 2021, expected to appreciate and reach $1745.69 million by 2030, confirms Strategic Market Research.

 

Market Drivers

  • The market is developing due to the increased use of surgical operations and minimally invasive procedures. Moreover, the growing number of gastrointestinal, gynecological, urological, and cardiac surgical procedures that require ligation devices for diagnostic and treatment processes is further driving the market.

  • According to a survey undertaken by the European Heart Network in 2017, cardiovascular diseases are responsible for 3.9 million deaths in Europe. As the number of diseases requiring minimally invasive operations rises, the demand for ligation devices also increases.

  • Due to the growing use of various innovative devices, methods, and treatment procedures like essure tubal ligation, adiana tubal occlusion, bilateral tubal ligation, intrauterine devices, contraceptive implants, postpartum tubal ligation, interval tubal ligation, bipolar coagulation, monopolar coagulation, tubal clipping, tubal ringing, uchida tubal ligation, adiana tubal ligation are propelling the growth of the market.

 

Ligation devices market Based on Market Share

 

Market Restraint

  • The expense of ligation devices used in surgical operations necessitates a more significant investment that limits the ligation devices market growth.

  • The rise of tubal ligation scars and Pelvic inflammatory disease are the factors restraining the market.

 

Market Opportunity

  • Increased healthcare expenditures, which can be used to cure various cardiovascular illnesses and other ailments, will aid the market's growth in the upcoming years. Moreover, an increase in the demand for minimally invasive treatments involving ligation devices and accessories will likely provide the lucrative potential for market expansion in the upcoming years.

 

Market Analysis of Different Segments Covered in the Report

By Product

  • Handheld instruments

  • Accessories

 

By Procedure

  • MIS

  • Open Surgery

 

By Application

  • Gastrointestinal & Abdominal Surgeries

  • Gynecological Surgeries

  • Cardiovascular Surgeries

  • Urological Surgeries

  • Other Applications

 

By End User

  • Hospitals

  • Other End Users

Ligation devices market Based on Application

 

By Region

North America

  • U.S.

  • Canada

  • Mexico

 

Europe

  • Germany

  • France

  • Italy

  • Switzerland

  • U.K.

  • Rest of Europe

 

Asia-Pacific

  • Japan

  • China

  • India

  • Rest of Asia-Pacific

 

LAMEA

  • Brazil

  • Israel

  • South Africa

  • Saudi Arabia

  • Rest of LAMEA

 

Based on Product, the 'accessories market segment accounted for more than 55 percent of the market in 2020. It is predicted to expedite at a CAGR of 6.9% over the projected period. The increasing number of surgical procedures, particularly in emerging nations, can be ascribed to this rise. Moreover, this segment is expected to develop due to its availability in various sizes and wide applications in surgical operations.

 

In 2020, the 'open surgery' segment accounted for a significant portion of the market for ligation devices, and it is predicted to continue to develop rapidly throughout the forecasted period. It is also expected to grow rapidly, primarily due to the advancement in the occurrences of heart disease and open-heart surgical procedures. Also, various types of open-heart surgical procedures, such as Coronary Artery Bypass Graft (CABG), aortic valve replacement, and mitral valve replacement requiring ligation devices, are driving the market to a great extent. According to the Adult Cardiac Surgery Database of the Society of Thoracic Surgeons, in the United States, 156,931 CABG procedures were performed in  2016, thus encouraging the uptake of ligation devices.

 

In 2020, the 'gastrointestinal and abdominal surgeries' accounted for the most significant market share. Moreover, during the projected period, the cardiovascular surgeries sector is expected to drive the market expansion at a CAGR of 6.9%. This is due to the rising occurrences of cardiovascular diseases. In addition, the market for ligation devices is expected to rise as technology advances in cardiovascular robotic surgery. Cardiovascular illness is responsible for 800,000 deaths in the United States, according to the American College of Cardiology (2017).

 

In 2020, the 'hospitals' segment held the largest ligation devices market share, with more than 75% of the entire market. Also, the segment's primary drivers include an increase in the number of procedures, an increase in healthcare spending, and an increase in the number of hospitals. According to the American Hospital Association (AHA), there were 6,200 active hospitals in the U.S. in 2017, increasing from 5,534 hospitals in 2016.

 

The Ambulatory Surgical Centers (ASCs) segment will have the most significant CAGR throughout the forecasted period. The increasing number of outpatient treatments and the expanding use of minimally invasive surgeries, which do not require lengthier hospital stays, contribute to the rapid rise. More than 40.7 Mn ambulatory visits for G.I. disorders are made annually in the United States. In addition, in 2017, the NIH (National Institutes of Health) allocated USD 1.8 billion to digestive disease research in the United States.

 

In 2020, North America dominated the ligation devices market because of increased healthcare costs and the prevalence of chronic conditions. According to the CDC (Centers for Disease Control and Prevention), coronary heart disease (CHD) was the most frequent type of cardiac disease in the United States in 2018, causing 370,000 deaths annually. Additionally, rising government investment and significant competitors are driving the market expansion. In 2015, gastrointestinal problems accounted for USD 135 billion in healthcare spending, far more than other common ailments. According to the National Center for Chronic Disease Prevention and Health Promotion, chronic kidney disease affected thirty million people in the U.S. in 2017.

 

Moreover, Asia Pacific is anticipated to grow quickly during the predicted period. The region's growth is driven by the enormous patient population and rapid infrastructural development in the APAC area. According to Monash University, the burden of bariatric surgery in Australia was rising in 2015, with roughly 15,000 surgical procedures conducted in the country.

 

Ligation devices market Based on Region

 

Ligation Devices Market Competitive Landscape Analysis

Ligation Devices Market Report Coverage

Report Attribute

Details

Forecast Period

2021 - 2030

The market size value in 2021

USD 992.94 Million

The revenue forecast in 2030

USD 1745.69 Million

Growth rate

CAGR of approximately 6.47%

The base year for estimation

2021

Historical data

2017 – 2020

Unit

USD Billion, CAGR (2021 - 2030)

Segmentation

By Product, By Procedure, By Application, By End-users, By Region

By Procedure

MIS, Open Surgery.

By Product

Handheld instruments, Accessories

By Application

Gastrointestinal & Abdominal Surgeries, Gynecological Surgeries, Cardiovascular Surgeries, Urological Surgeries, Other Applications.

By End User

Hospitals, Other End Users

By Region

North America, Europe, Asia Pacific, LAMEA

Country Scope

United States of America, United Kingdom, Italy, Germany, France, Spain, Canada, China, India, Japan, Brazil, Argentina, Mexico, South Africa, Saudi Arabia, etc.

Company Usability Profiles

Ethicon, ConMed Corporation, Olympus Corporation, Applied Medical, B.Braun Melsungen AG, Cooper Surgical, Genicom, Grena Think Medical, Teleflex Incorporated, Medtronic.

Recent Developments

  • On the 3rd of May, 2021, CooperSurgical acquired OBP Medical Corporation, a U.S.-based medical device firm that develops and manufactures innovative products such as single-use vaginal speculums with integrated LED illumination.

  • In August 2019, the re-availability of Medtronic Plc's two product codes, FF107-ligation clip applier and FFL112-ligation clip applier, was confirmed.

  • In 2018, Genicon, Inc. entered into a distribution agreement with Greenpine Pharma, China, to distribute its complete products in China.

Frequently Asked Question About This Report

b: The key players in the market are Ethicon (Johnson and Johnson), ConMed Corporation, Olympus Corporation, Applied Medical, B.Braun Melsungen AG, Cooper Surgical, Genicom, Grena Think Medical, Teleflex Incorporated, Medtronic.

b: The accessories is the leading Product for the market.

b: The hospitals is the leading End- User for the market.

b: The North American region has the largest share in the market.

b: The global ligation devices market is expected to grow at a compound annual growth rate (CAGR) of 6.47% from 2021 to 2030 to reach USD 1745.69 Million by 2030.

b: The global ligation devices market size was $992.94 Mn in 2021 and is predicted to reach $1745.69 Mn by 2030, representing a CAGR of 6.47%.

Sources

https://ehnheart.org/publications-and-papers/publications/1202:heart-failure-and-cardiovascular-diseases.html

https://cardiothoracicsurgery.biomedcentral.com/articles/10.1186/s13019-021-01556-1

https://www.cdc.gov/heartdisease/facts.htm

https://www.cdc.gov/kidneydisease/publications-resources/ckd-national-facts.html